Cargando…

Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden

IMPORTANCE: Breast cancer (BC), the most prevalent cancer among women globally, is a heterogeneous disease, with prognosis differing by estrogen receptor (ER) status. Having a family history of BC increases the risk of BC; however, it is unclear whether family history is associated with the prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuqi, Wang, Qiao-Li, Zeng, Erwei, He, Wei, Czene, Kamila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265300/ https://www.ncbi.nlm.nih.gov/pubmed/37310740 http://dx.doi.org/10.1001/jamanetworkopen.2023.18053

Ejemplares similares

Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers
por: Wang, Qiao-Li, et al.
Publicado: (2023)

Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden
por: Johansson, Annelie, et al.
Publicado: (2021)

Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2023)

The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden
por: Sackey, Helena, et al.
Publicado: (2016)

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast
por: Gabrielson, Marike, et al.
Publicado: (2018)

Estrogen Receptor Status in Relation to Risk of Contralateral Breast Cancer–A Population-Based Cohort Study
por: Sandberg, Maria E. C., et al.
Publicado: (2012)

Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Zeng, Erwei, et al.
Publicado: (2022)

Coffee consumption modifies risk of estrogen-receptor negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2011)

Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes
por: Clelland, Elle N., et al.
Publicado: (2023)

Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
por: Han, Yunan, et al.
Publicado: (2022)

Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer
por: Li, Jingmei, et al.
Publicado: (2018)

Breast Cancer Incidence After a False-Positive Mammography Result
por: Mao, Xinhe, et al.
Publicado: (2023)

Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
por: Houghton, Lauren C., et al.
Publicado: (2019)

A constant risk for familial breast cancer? A population-based family study
por: Czene, Kamila, et al.
Publicado: (2009)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer
por: Abdel-Fatah, Tarek M. A., et al.
Publicado: (2020)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

Family History and Breast Cancer Hormone Receptor Status in a Spanish Cohort
por: Jiang, Xuejuan, et al.
Publicado: (2012)

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer
por: Andersson, Ulrika, et al.
Publicado: (2014)

Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer
por: Carleton, Neil, et al.
Publicado: (2021)

Missing Components of Receptor Status Among Women With Invasive Breast Cancer
por: Stephens, Julie A., et al.
Publicado: (2023)

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
por: Lindström, Linda S, et al.
Publicado: (2018)

Validation of Six Genetic Determinants of Susceptibility to Estrogen-Induced Mammary Cancer in the Rat and Assessment of Their Relevance to Breast Cancer Risk in Humans
por: Colletti, John A., et al.
Publicado: (2014)

Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer
por: Hynes, NE, et al.
Publicado: (2001)

Gene expression signature of estrogen receptor α status in breast cancer
por: Abba, Martín C, et al.
Publicado: (2005)

Breast cancer: age incidence, hormone receptor status and family history in Najaf, Iraq
por: Khalaf, Hasan, et al.
Publicado: (2022)

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
por: Feng, Helian, et al.
Publicado: (2020)

Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
por: Prochazka, M, et al.
Publicado: (2006)

Estrogen Receptors in Human Breast Cancer
por: Skinner, Louis G.
Publicado: (1976)

Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)

A genome-wide association scan on estrogen receptor-negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2010)

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis
por: Tan, Weige, et al.
Publicado: (2016)

Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors
por: Alsheh Ali, Maya, et al.
Publicado: (2019)

Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status
por: Rotunno, Melissa, et al.
Publicado: (2014)

Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status
por: Malkov, Serghei, et al.
Publicado: (2016)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Sestak, Ivana, et al.
Publicado: (2018)

Association of Neighborhood-Level Household Income With 21-Gene Recurrence Score and Survival Among Patients With Estrogen Receptor–Positive Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2023)

Breast Tissue Organisation and its Association with Breast Cancer Risk
por: Ali, Maya Alsheh, et al.
Publicado: (2017)

Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden
por: Hu, Kejia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3uqr0sbj8kp1uc17u328jstj0